drugset / Trial / NCT00787618
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
Non-randomizedParallel-groupOpen-label
Summary
PK and safety profile of Proellex® in females with various stages of impaired renal function
Timeline
- Start
- 2008-10
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Telapristone Acetate | Other / unclassified | 50 mg | — |